Arcam AB fka AMAVF

[BiotechValues]

With Fundamentals in focus (as they should be) I have to think Arcam will be standing out in the coming days/weeks based on organic growth rate, lack of dilution, etc. Too many mainstream publications only cover DDD, SSYS, XONE, VJET numbers- that's been changing, although slowly over the last 2 years.

I think the 2014 report and prospects for 2015 will continue to bring awareness to this industry standout.

ARCM.ST is the only pure play 3D printer OEM that's up YTD, and we all know that's because of the company's fundamentals. Here's to more people discovering those fundamentals in the coming days/weeks!